Dalian BIO-CHEM Company Limited
603360.SS · SHH
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | CN¥1,312 | CN¥1,066 | CN¥1,257 | CN¥1,006 |
| % Growth | 23.1% | -15.2% | 24.9% | – |
| Cost of Goods Sold | CN¥738 | CN¥521 | CN¥616 | CN¥557 |
| Gross Profit | CN¥574 | CN¥545 | CN¥641 | CN¥450 |
| % Margin | 43.8% | 51.1% | 51% | 44.7% |
| R&D Expenses | CN¥50 | CN¥39 | CN¥47 | CN¥40 |
| G&A Expenses | CN¥93 | CN¥107 | CN¥121 | CN¥79 |
| SG&A Expenses | CN¥111 | CN¥121 | CN¥132 | CN¥92 |
| Sales & Mktg Exp. | CN¥18 | CN¥14 | CN¥11 | CN¥12 |
| Other Operating Expenses | -CN¥1 | -CN¥1 | -CN¥0 | CN¥15 |
| Operating Expenses | CN¥159 | CN¥159 | CN¥179 | CN¥147 |
| Operating Income | CN¥415 | CN¥386 | CN¥462 | CN¥303 |
| % Margin | 31.6% | 36.2% | 36.7% | 30.1% |
| Other Income/Exp. Net | -CN¥0 | -CN¥0 | -CN¥0 | -CN¥11 |
| Pre-Tax Income | CN¥414 | CN¥386 | CN¥461 | CN¥292 |
| Tax Expense | CN¥55 | CN¥57 | CN¥59 | CN¥42 |
| Net Income | CN¥345 | CN¥328 | CN¥403 | CN¥250 |
| % Margin | 26.3% | 30.8% | 32% | 24.9% |
| EPS | 0.68 | 0.66 | 1.2 | 0.71 |
| % Growth | 3% | -45% | 69% | – |
| EPS Diluted | 0.68 | 0.93 | 1.2 | 0.71 |
| Weighted Avg Shares Out | 508 | 353 | 335 | 351 |
| Weighted Avg Shares Out Dil | 508 | 353 | 335 | 354 |
| Supplemental Information | – | – | – | – |
| Interest Income | CN¥17 | CN¥19 | CN¥4 | CN¥6 |
| Interest Expense | CN¥8 | CN¥5 | CN¥5 | CN¥13 |
| Depreciation & Amortization | CN¥69 | CN¥64 | CN¥71 | CN¥48 |
| EBITDA | CN¥464 | CN¥440 | CN¥517 | CN¥353 |
| % Margin | 35.3% | 41.3% | 41.1% | 35.1% |